2021 Q4 Form 10-Q Financial Statement

#000172894922000012 Filed on February 02, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2020 Q4
Revenue $10.71B $8.235B
YoY Change 29.99% 62.2%
Cost Of Revenue $4.303B $3.489B
YoY Change 23.33% 65.12%
Gross Profit $6.402B $4.746B
YoY Change 34.89% 60.12%
Gross Profit Margin 59.8% 57.63%
Selling, General & Admin $608.0M $567.0M
YoY Change 7.23% 7.39%
% of Gross Profit 9.5% 11.95%
Research & Development $1.930B $1.653B
YoY Change 16.76% 17.57%
% of Gross Profit 30.15% 34.83%
Depreciation & Amortization $406.0M $364.0M
YoY Change 11.54% 3.7%
% of Gross Profit 6.34% 7.67%
Operating Expenses $2.538B $2.220B
YoY Change 14.32% 14.79%
Operating Profit $3.864B $2.526B
YoY Change 52.97% 145.24%
Interest Expense $139.0M $141.0M
YoY Change -1.42% -4.73%
% of Operating Profit 3.6% 5.58%
Other Income/Expense, Net
YoY Change
Pretax Income $3.865B $2.604B
YoY Change 48.43% 174.97%
Income Tax $466.0M $149.0M
% Of Pretax Income 12.06% 5.72%
Net Earnings $3.399B $2.455B
YoY Change 38.45% 165.41%
Net Earnings / Revenue 31.75% 29.81%
Basic Earnings Per Share $3.02 $2.16
Diluted Earnings Per Share $2.98 $2.12
COMMON SHARES
Basic Shares Outstanding 1.124B shares 1.134B shares
Diluted Shares Outstanding 1.142B shares 1.156B shares

Balance Sheet

Concept 2021 Q4 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.61B $12.30B
YoY Change -13.73% 7.66%
Cash & Equivalents $6.607B $7.076B
Short-Term Investments $4.003B $5.222B
Other Short-Term Assets $1.019B $794.0M
YoY Change 28.34% 27.04%
Inventory $3.861B $2.552B
Prepaid Expenses
Receivables $4.032B $4.148B
Other Receivables $0.00 $0.00
Total Short-Term Assets $20.22B $19.79B
YoY Change 2.17% 22.14%
LONG-TERM ASSETS
Property, Plant & Equipment $4.723B $4.033B
YoY Change 17.11% 27.18%
Goodwill $7.264B $6.358B
YoY Change 14.25% 0.97%
Intangibles $1.373B $1.541B
YoY Change -10.9% -24.65%
Long-Term Investments $35.00M
YoY Change
Other Assets $7.784B $4.436B
YoY Change 75.47% 7.18%
Total Long-Term Assets $22.60B $17.69B
YoY Change 27.77% 4.62%
TOTAL ASSETS
Total Short-Term Assets $20.22B $19.79B
Total Long-Term Assets $22.60B $17.69B
Total Assets $42.82B $37.48B
YoY Change 14.25% 13.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.526B $2.429B
YoY Change 45.16% 41.39%
Accrued Expenses $1.440B $1.149B
YoY Change 25.33% 6.88%
Deferred Revenue
YoY Change
Short-Term Debt $2.042B $500.0M
YoY Change 308.4% 0.2%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.27B $9.223B
YoY Change 33.07% 0.32%
LONG-TERM LIABILITIES
Long-Term Debt $13.71B $15.23B
YoY Change -10.0% 13.35%
Other Long-Term Liabilities $5.506B $5.645B
YoY Change -2.46% -5.4%
Total Long-Term Liabilities $19.21B $20.88B
YoY Change -7.96% 7.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.27B $9.223B
Total Long-Term Liabilities $19.21B $20.88B
Total Liabilities $31.49B $30.10B
YoY Change 4.61% 5.25%
SHAREHOLDERS EQUITY
Retained Earnings $11.28B $6.974B
YoY Change 61.67% 59.37%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.33B $7.380B
YoY Change
Total Liabilities & Shareholders Equity $42.82B $37.48B
YoY Change 14.25% 13.19%

Cashflow Statement

Concept 2021 Q4 2020 Q4
OPERATING ACTIVITIES
Net Income $3.399B $2.455B
YoY Change 38.45% 165.41%
Depreciation, Depletion And Amortization $406.0M $364.0M
YoY Change 11.54% 3.7%
Cash From Operating Activities $2.057B $3.175B
YoY Change -35.21% 183.99%
INVESTING ACTIVITIES
Capital Expenditures -$583.0M -$469.0M
YoY Change 24.31% 58.45%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$31.00M
YoY Change -100.0% -36.73%
Cash From Investing Activities -$112.0M -$1.202B
YoY Change -90.68% 492.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.178B $444.0M
YoY Change 165.32% -39.92%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$2.446B -$1.645B
YoY Change 48.69% -0.84%
NET CHANGE
Cash From Operating Activities $2.057B $3.175B
Cash From Investing Activities -$112.0M -$1.202B
Cash From Financing Activities -$2.446B -$1.645B
Net Change In Cash -$509.0M $369.0M
YoY Change -237.94% -150.55%
FREE CASH FLOW
Cash From Operating Activities $2.057B $3.175B
Capital Expenditures -$583.0M -$469.0M
Free Cash Flow $2.640B $3.644B
YoY Change -27.55% 157.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 dei Entity Registrant Name
EntityRegistrantName
QUALCOMM INC/DE
CY2021Q4 dei Entity Central Index Key
EntityCentralIndexKey
0000804328
CY2021Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q4 dei Amendment Flag
AmendmentFlag
false
CY2021Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-25
CY2021Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P0Y9M0D
CY2021Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y0M0D
CY2021Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y0M0D
CY2021Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y0M0D
CY2021Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y0M0D
CY2021Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y0M0D
CY2021Q4 dei Document Type
DocumentType
10-Q
CY2021Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q4 dei Document Period End Date
DocumentPeriodEndDate
2021-12-26
CY2021Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q4 dei Entity File Number
EntityFileNumber
0-19528
CY2021Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
95-3685934
CY2021Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
5775 Morehouse Dr.
CY2021Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
CY2021Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92121-1714
CY2021Q4 dei City Area Code
CityAreaCode
(858)
CY2021Q4 dei Local Phone Number
LocalPhoneNumber
587-1121
CY2021Q4 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value
CY2021Q4 dei Trading Symbol
TradingSymbol
QCOM
CY2021Q4 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q4 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q4 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q4 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1127000000 shares
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6607000000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7116000000 USD
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
4703000000 USD
CY2021Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
5298000000 USD
CY2021Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
4032000000 USD
CY2021Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
3579000000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
3861000000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
3228000000 USD
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1019000000 USD
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
854000000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
20222000000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
20075000000 USD
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1454000000 USD
CY2021Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1591000000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4723000000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4559000000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
7264000000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
7246000000 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1373000000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1458000000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7784000000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6311000000 USD
CY2021Q4 us-gaap Assets
Assets
42820000000 USD
CY2021Q3 us-gaap Assets
Assets
41240000000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3526000000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2750000000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1440000000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1531000000 USD
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000 shares
CY2021Q3 us-gaap Debt Current
DebtCurrent
2044000000 USD
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
604000000 USD
CY2021Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
612000000 USD
CY2021Q4 us-gaap Debt Current
DebtCurrent
2042000000 USD
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4661000000 USD
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5014000000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12273000000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
11951000000 USD
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
257000000 USD
CY2021Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
364000000 USD
CY2021Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1687000000 USD
CY2021Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1713000000 USD
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
13708000000 USD
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
13701000000 USD
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
3562000000 USD
CY2021Q3 us-gaap Other Liabilities
OtherLiabilities
3561000000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
31487000000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
31290000000 USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
8000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
8000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1125000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1125000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1125000000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1125000000 shares
CY2021Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
0 USD
CY2021Q3 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
0 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
11275000000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
9822000000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
58000000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
128000000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11333000000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9950000000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
42820000000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
41240000000 USD
CY2021Q4 qcom Equipment And Services
EquipmentAndServices
8682000000 USD
CY2020Q4 qcom Equipment And Services
EquipmentAndServices
6442000000 USD
CY2021Q4 qcom Licensing Revenues
LicensingRevenues
2023000000 USD
CY2020Q4 qcom Licensing Revenues
LicensingRevenues
1793000000 USD
CY2021Q4 us-gaap Revenues
Revenues
10705000000 USD
CY2020Q4 us-gaap Revenues
Revenues
8235000000 USD
CY2021Q4 us-gaap Cost Of Revenue
CostOfRevenue
4303000000 USD
CY2020Q4 us-gaap Cost Of Revenue
CostOfRevenue
3489000000 USD
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1930000000 USD
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1653000000 USD
CY2021Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
608000000 USD
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
567000000 USD
CY2021Q4 us-gaap Costs And Expenses
CostsAndExpenses
6841000000 USD
CY2020Q4 us-gaap Costs And Expenses
CostsAndExpenses
5709000000 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
3864000000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
2526000000 USD
CY2021Q4 us-gaap Interest Expense
InterestExpense
139000000 USD
CY2020Q4 us-gaap Interest Expense
InterestExpense
141000000 USD
CY2021Q4 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
140000000 USD
CY2020Q4 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
219000000 USD
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3865000000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2604000000 USD
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
466000000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
149000000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
3399000000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
2455000000 USD
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.02
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.16
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.98
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.12
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1124000000 shares
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1134000000 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1142000000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1156000000 shares
CY2021Q4 us-gaap Profit Loss
ProfitLoss
3399000000 USD
CY2020Q4 us-gaap Profit Loss
ProfitLoss
2455000000 USD
CY2021Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-42000000 USD
CY2020Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
87000000 USD
CY2021Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-19000000 USD
CY2020Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3000000 USD
CY2021Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
2000000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
10000000 USD
CY2021Q4 qcom Other Gains Losses Other Comprehensive Income
OtherGainsLossesOtherComprehensiveIncome
0 USD
CY2020Q4 qcom Other Gains Losses Other Comprehensive Income
OtherGainsLossesOtherComprehensiveIncome
3000000 USD
CY2021Q4 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
11000000 USD
CY2020Q4 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
11000000 USD
CY2021Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-70000000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
86000000 USD
CY2021Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3329000000 USD
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2541000000 USD
CY2021Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1504000000 USD
CY2020Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
97000000 USD
CY2021Q4 us-gaap Profit Loss
ProfitLoss
3399000000 USD
CY2020Q4 us-gaap Profit Loss
ProfitLoss
2455000000 USD
CY2021Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
406000000 USD
CY2020Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
364000000 USD
CY2021Q4 qcom Income Tax Provision Less Than In Excess Of Income Tax Payments
IncomeTaxProvisionLessThanInExcessOfIncomeTaxPayments
272000000 USD
CY2020Q4 qcom Income Tax Provision Less Than In Excess Of Income Tax Payments
IncomeTaxProvisionLessThanInExcessOfIncomeTaxPayments
53000000 USD
CY2021Q4 us-gaap Share Based Compensation
ShareBasedCompensation
496000000 USD
CY2020Q4 us-gaap Share Based Compensation
ShareBasedCompensation
392000000 USD
CY2021Q4 us-gaap Gain Loss On Investments
GainLossOnInvestments
103000000 USD
CY2020Q4 us-gaap Gain Loss On Investments
GainLossOnInvestments
195000000 USD
CY2021Q4 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
25000000 USD
CY2020Q4 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
18000000 USD
CY2021Q4 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
454000000 USD
CY2020Q4 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
141000000 USD
CY2021Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
638000000 USD
CY2020Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-62000000 USD
CY2021Q4 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
781000000 USD
CY2020Q4 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
129000000 USD
CY2021Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-495000000 USD
CY2020Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
278000000 USD
CY2021Q4 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-78000000 USD
CY2020Q4 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-107000000 USD
CY2021Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2057000000 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3175000000 USD
CY2021Q4 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
583000000 USD
CY2020Q4 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
469000000 USD
CY2021Q4 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
517000000 USD
CY2020Q4 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
2248000000 USD
CY2021Q4 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1133000000 USD
CY2020Q4 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1612000000 USD
CY2021Q4 qcom Acquisitions And Other Investments Netof Cash Acquired
AcquisitionsAndOtherInvestmentsNetofCashAcquired
238000000 USD
CY2020Q4 qcom Acquisitions And Other Investments Netof Cash Acquired
AcquisitionsAndOtherInvestmentsNetofCashAcquired
138000000 USD
CY2021Q4 qcom Proceedsfromotherinvestments
Proceedsfromotherinvestments
93000000 USD
CY2020Q4 qcom Proceedsfromotherinvestments
Proceedsfromotherinvestments
10000000 USD
CY2021Q4 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2020Q4 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-31000000 USD
CY2021Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-112000000 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1202000000 USD
CY2021Q4 us-gaap Proceeds From Issuance Of Commercial Paper
ProceedsFromIssuanceOfCommercialPaper
710000000 USD
CY2020Q4 us-gaap Proceeds From Issuance Of Commercial Paper
ProceedsFromIssuanceOfCommercialPaper
819000000 USD
CY2021Q4 us-gaap Repayments Of Commercial Paper
RepaymentsOfCommercialPaper
710000000 USD
CY2020Q4 us-gaap Repayments Of Commercial Paper
RepaymentsOfCommercialPaper
818000000 USD
CY2021Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1178000000 USD
CY2020Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
444000000 USD
CY2021Q4 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
765000000 USD
CY2020Q4 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
739000000 USD
CY2021Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
500000000 USD
CY2020Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
449000000 USD
CY2021Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1486000000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6707000000 USD
CY2021Q4 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-3000000 USD
CY2020Q4 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-14000000 USD
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2446000000 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1645000000 USD
CY2021Q4 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-8000000 USD
CY2020Q4 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
41000000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-509000000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
369000000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7116000000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6607000000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7076000000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9950000000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6077000000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11333000000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7380000000 USD
CY2021Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.68
CY2020Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.65
CY2021Q4 us-gaap Fiscal Period
FiscalPeriod
We operate and report using a 52-53 week fiscal year ending on the last Sunday in September. Each of the three months ended December 26, 2021 and December 27, 2020 included 13 weeks.
CY2021Q4 us-gaap Use Of Estimates
UseOfEstimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of contingent amounts in our condensed consolidated financial statements and the accompanying notes. Actual results could differ from those estimates.
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
243000000 USD
CY2021Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
267000000 USD
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2125000000 USD
CY2021Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1475000000 USD
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1493000000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
3861000000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
3228000000 USD
CY2021Q4 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
242000000 USD
CY2020Q4 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
110000000 USD
CY2021Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
187000000 USD
CY2020Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
185000000 USD
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
969000000 USD
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
508000000 USD
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
332000000 USD
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
94000000 USD
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
33000000 USD
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2000000 USD
CY2020Q4 us-gaap Impairment Of Investments
ImpairmentOfInvestments
1000000 USD
CY2021Q4 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-13000000 USD
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0 USD
CY2021Q4 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
17000000 USD
CY2020Q4 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
21000000 USD
CY2021Q4 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
17000000 USD
CY2020Q4 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
118000000 USD
CY2021Q4 us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
93000000 USD
CY2020Q4 us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
34000000 USD
CY2021Q4 qcom Net Losses Gains On Deferred Compensation Plan Assets
NetLossesGainsOnDeferredCompensationPlanAssets
13000000 USD
CY2020Q4 qcom Net Losses Gains On Deferred Compensation Plan Assets
NetLossesGainsOnDeferredCompensationPlanAssets
54000000 USD
CY2021Q4 us-gaap Impairment Of Investments
ImpairmentOfInvestments
1000000 USD
CY2020Q4 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
219000000 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2100000000 USD
CY2020Q4 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
9000000 USD
CY2021Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7000000 USD
CY2020Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2000000 USD
CY2021Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
7000000 USD
CY2020Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-14000000 USD
CY2021Q4 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
140000000 USD
CY2021Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.12
CY2020Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.06
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2100000000 USD
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1125000000 shares
CY2021Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
8000000 shares
CY2021Q4 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
8000000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1125000000 shares
CY2021Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
18000000 shares
CY2020Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
22000000 shares
CY2021Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2020Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2021Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 USD
CY2021Q4 us-gaap Revenues
Revenues
10705000000 USD
CY2020Q4 us-gaap Revenues
Revenues
8235000000 USD
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3865000000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2604000000 USD
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
4703000000 USD
CY2021Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
5298000000 USD
CY2021Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
16900000000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
4003000000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
4616000000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
566000000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
3300000000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
137000000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4003000000 USD

Files In Submission

Name View Source Status
0001728949-22-000012-index-headers.html Edgar Link pending
0001728949-22-000012-index.html Edgar Link pending
0001728949-22-000012.txt Edgar Link pending
0001728949-22-000012-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qcom-20211226.htm Edgar Link pending
qcom-20211226.xsd Edgar Link pending
qcom-20211226_cal.xml Edgar Link unprocessable
qcom-20211226_def.xml Edgar Link unprocessable
qcom-20211226_htm.xml Edgar Link completed
qcom-20211226_lab.xml Edgar Link unprocessable
qcom-20211226_pre.xml Edgar Link unprocessable
qcom12262021ex1025.htm Edgar Link pending
qcom12262021ex1026.htm Edgar Link pending
qcom122621ex311.htm Edgar Link pending
qcom122621ex312.htm Edgar Link pending
qcom122621ex321.htm Edgar Link pending
qcom122621ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending